Revvity Launches AI-Powered Preclinical Imaging Analysis Platform
New software further strengthens Revvity’s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights
Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities—reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating…
